相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GHR signalling: Receptor activation and degradation mechanisms
Yash Chhabra et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line
Alexey Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients
Tali Sinai-Livne et al.
Oncotarget (2020)
Role of the GH-IGF1 system in progression of cancer
Haim Werner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
Haim Werner et al.
CELLS (2020)
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
Haim Werner et al.
CELLS (2019)
Olfactory receptor gene abundance in invasive breast carcinoma
Shirin Masjedi et al.
SCIENTIFIC REPORTS (2019)
The diversified function and potential therapy of ectopic olfactory receptors in non-olfactory tissues
Zhe Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
HUMAN OLFACTORY RECEPTORS: NOVEL CELLULAR FUNCTIONS OUTSIDE OF THE NOSE
Desiree Massberg et al.
PHYSIOLOGICAL REVIEWS (2018)
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy
Rena Morita et al.
CLINICAL CANCER RESEARCH (2016)
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Valentine M. Macaulay et al.
CLINICAL CANCER RESEARCH (2016)
Identification of signaling pathways associated with cancer protection in Laron syndrome
Lena Lapkina-Gendler et al.
ENDOCRINE-RELATED CANCER (2016)
The growth hormone receptor
Michael J. Waters
GROWTH HORMONE & IGF RESEARCH (2016)
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
Leonard Girnita et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Transcriptional and epigenetic control of IGF1R gene expression: Implications in metabolism and cancer
Haim Werner et al.
GROWTH HORMONE & IGF RESEARCH (2014)
The IGF hormonal network in endometrial cancer: functions, regulation, and targeting approaches
Ilan Bruchim et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer
Connie Bitelman et al.
CANCER LETTERS (2013)
Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas
Tao Cui et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Targeting IGF-1 signaling pathways in gynecologic malignancies
Ilan Bruchim et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids
Valeria Giandomenico et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Insulin-Like Growth Factor Physiology What we have Learned from Human Studies
Jeff M. P. Holly et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Insulin-Like Growth Factor-1 Physiology: Lessons from Mouse Models
Shoshana Yakar et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy
Zohar Attias-Geva et al.
EUROPEAN JOURNAL OF CANCER (2012)
Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies
Rachel Steuerman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
Jaime Guevara-Aguirre et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Endometrial glandular dysplasia with frequent p53 gene mutation: A genetic evidence supporting its precancer nature for endometrial serous carcinoma
Lin Jia et al.
CLINICAL CANCER RESEARCH (2008)
IGF signaling defects as causes of growth failure and IUGR
Juergen Klammt et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary report
O. Shevah et al.
GROWTH HORMONE & IGF RESEARCH (2007)
PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer
JS Weng et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
CA Hamilton et al.
BRITISH JOURNAL OF CANCER (2006)
Quantitative expression profile of PSGR in prostate cancer
LL Xu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
Extensive personal experience - Laron syndrome (primary growth hormone resistance or insensitivity): The personal experience 1958-2003
Z Laron
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
